BioScience Health Innovations Files Q1 2025 10-Q

TL;DR

BioScience Health Innovations (formerly Nowtransit) filed its Q1 2025 10-Q. Based in NV.

AI Summary

BioScience Health Innovations, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, formerly known as Nowtransit Inc., is incorporated in Nevada and operates in the computer processing and data preparation sector. Its principal business address is in Salt Lake City, UT.

Why It Matters

This filing provides investors with an update on the company's financial performance and operational status for the first quarter of 2025.

Risk Assessment

Risk Level: low — This is a routine quarterly filing with no immediate red flags or significant new information presented in the provided text.

Key Numbers

• 333-234487 — SEC File Number (Identifies the company's filing with the SEC)
• 0001784440 — Central Index Key (Unique identifier for the company in the SEC EDGAR system)

Key Players & Entities

• BioScience Health Innovations, Inc. (company) — Registrant
• March 31, 2025 (date) — Quarterly period end date
• Nowtransit Inc. (company) — Former company name
• Nevada (jurisdiction) — State of incorporation
• Salt Lake City, UT (location) — Business address

FAQ

From the Filing

0001185185-25-000413.txt : 20250508 0001185185-25-000413.hdr.sgml : 20250508 20250508124113 ACCESSION NUMBER: 0001185185-25-000413 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 38 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250508 DATE AS OF CHANGE: 20250508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioScience Health Innovations, Inc. CENTRAL INDEX KEY: 0001784440 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] ORGANIZATION NAME: 06 Technology EIN: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-234487 FILM NUMBER: 25924974 BUSINESS ADDRESS: STREET 1: 2722 S WEST TEMPLE CITY: SALT LAKE CITY STATE: UT ZIP: 84115 BUSINESS PHONE: 801-949-0791 MAIL ADDRESS: STREET 1: 2722 S WEST TEMPLE CITY: SALT LAKE CITY STATE: UT ZIP: 84115 FORMER COMPANY: FORMER CONFORMED NAME: Nowtransit Inc DATE OF NAME CHANGE: 20190802 10-Q 1 notr10q033125.htm FORM 10-Q     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549         FORM 10-Q       Mark One   ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the quarterly period ended March 31, 2025   ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   For the transition period from                             to                              Commission File No. 333-234487   BIOSCIENCE HEALTH INNOVATIONS INC. (Exact name of registrant as specified in its charter)   Nevada   7374   98-1498782 (State or Other Jurisdiction of   (Primary Standard Industrial   (IRS Employer Incorporation or Organization)   Classification Number)   Identification Number)   2722 South West Temple Salt Lake City , UT 84115 (Address of principal executive offices)   Registrant’s telephone number, including area code: (801) 949-0791   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered None   None   None   Securities registered pursuant to Section 12(g) of the Act: Common stock, par value $0.0001   Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐   Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐   Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.   Large accelerated filer ☐ Accelerated Filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☒     If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a)